Samsung Biologics
🇰🇷 South Korea · Biopharmaceuticals · 207940.KS
Contract manufacturer (CDMO) for biologic drugs.
Market capitalization
USD 54.3B
2025
+20.1%
2024→2025
| 2020 | USD 50.3B |
| 2021 | USD 50.2B |
| 2022 | USD 46.1B |
| 2023 | USD 41.8B |
| 2024 | USD 45.2B |
| 2025 | USD 54.3B |
Source: companiesmarketcap.com — Samsung Biologics
All top companies in 🇰🇷 South Korea→